Exenatide Use in the Management of Type 2 Diabetes Mellitus

Exenatide Use in the Management of Type 2 Diabetes Mellitus

Exenatide is a GLP-1 (glucagon-like peptide-1) agonist that has been approved in the UK for use in the management of Type 2 Diabetes Mellitus (T2DM) since 2006. It acts by increasing glucose-induced insulin release and by reducing glucagon secretion postprandially. It therefore increases insulin sec...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Angelos Kyriacou, Abu Baker Ahmed
Format: Artykuł
Język:English
Wydane: MDPI AG 2010-08-01
Seria:Pharmaceuticals
Hasła przedmiotowe:
diabetes
exenatide
glycaemic control
incretin mimetics
efficacy
adverse events
Dostęp online:http://www.mdpi.com/1424-8247/3/8/2554/

Internet

http://www.mdpi.com/1424-8247/3/8/2554/

Podobne zapisy